对抑郁患者的S-adenosyl-L-methionine (SAMe) 的有效性和可接受性:系统性审查和元分析
Nahathai Limveeraprajak1, Sirapop Nakhawatchana1, Apidsada Visukamol1
1Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
S-adenosyl-L-methionine (SAMe) 单疗法在缓解抑郁症症状方面显示出适度的疗效和良好的可接受性. 然而,其作为抗抑郁药的补充剂或与抗抑郁药单独相比的有效性需要进一步调查.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抑郁症是一种普遍的情绪障碍,具有重大的全球健康影响.
- S-adenosyl-L-methionine (SAMe) 是一种内源性化合物,参与神经递质合成,研究其抗抑郁性质.
结论:
- 中等确定性证据表明,SAME单一疗法对抑郁症提供了中等的治疗效益.
- SAMe单一疗法表现出有利的可接受性概况,值得考虑作为一种治疗选择.
- 需要进一步的研究来澄清SAME作为辅助疗法的有效性及其与标准抗抑郁药的比较有效性.
更多相关视频
07:05Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
Published on: January 3, 2017
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
Depression: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Electroconvulsive Therapy
Alzheimer's Disease: Treatment
Antidepressant Drugs: Overview
